749
edits
Changes
Jump to navigation
Jump to search
no edit summary
Many ICRP publications feature their own glossaries including, for example, highly specialized terms relevant to that specific publication or helpful for a reader to have close at hand, or when introducing new terms to be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in [[ICRP publications]].
----
{| class="wikitable"
|-
| [[#09|0-9]] || [[#A|A]] || [[#B|B]] || [[#C|C]]|| [[#D|D]] || [[#E|E]] || [[#F|F]] || [[#G|G]] || [[#H|H]] || [[#I|I]] || [[#J|J]] || [[#K|K]] || [[#L|L]] || [[#M|M]] ||[[#N|N]] || [[#O|O]] || [[#P|P]] || [[#Q|Q]] || [[#R|R]] || [[#S|S]] || [[#T|T]] || [[#U|U]] || [[#V|V]] || [[#W|W]] || [[#X|X]] || [[#Y|Y]] || [[#Z|Z]] || [[#ZZ|...]]
|}
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
=== <big><span id="09">0-9</span></big> ===
*4DCT (see [[Time-resolved computed tomography]])
=== <big><span id="A">A</span></big> ===
*[[Accountability]]
*[[Accreditation]]
*[[Action Level]]
*[[Activation]]
*[[Active detection system]]
*[[Active (red) bone marrow]]
*[[Acute radiation syndrome]]
*[[Additional dose]]
*[[Adaptive response]]
*[[Air-kerma, product]]
*[[ALARA]]
*ALI (see [[Annual limit on intake]])
*[[Alimentary tract transfer factor]]
*[[Allometry]]
*[[Alpha decay]]
*[[Autoimmune disease]]
*[[Automatic exposure control]]
*[[Autonomy]]
*[[Background dose (rate)]]
*[[Backscatter detection system]]
*[[Backscatter factor]]
*[[Class SR-2 gases]]
*[[Clearance]]
*[[Clearance level]]
*[[Cobblestone area forming cell assay]]
*[[Collective dose]]
*[[Co-expertise]]
*[[Collective dose]]
*[[Collective effective dose]], S
*[[Collimation]]
*[[Colony]]
*[[Commissioning]]
*[[Committed effective dose]]
*[[Compartment]]
*[[Compartment (environmental)]]
*[[Complex tissues]]
*[[Computed tomography dose index]]
*[[Concentration ratio]]
*[[Cone beam computed tomography]]
*[[Constancy test]]
*[[Containment]]
*[[Contamination]]
*[[Coronary heart disease]]
*[[Cosmic radiation]]
*[[Cost-benefit analysis]]
*[[Coster-Kronig transition]]
*CR (see [[Concentration ratio]])
*[[Cross section]]
*Cumulative air kerma (see [[Cumulative air Air kermaat the patient entrance reference point]])
*[[Cumulative dose]]
*DAC (see [[Derived air concentration]])
*DBT (see [[Digital breast tomosynthesis]])
*DCRL (see [[Derived consideration reference level]])
*DD (see [[Doubling dose]])
*DDI, detector dose indicator (see [[Exposure index]])
*DIL (see [[Derived investigation level]])
*[[Decontamination factor]]
*[[Dental and maxillofacial imaging]]
*[[Deontological Ethics]]
*[[Deposition]](inhalation)
*[[Derived air concentration]]
*[[Derived consideration reference level]]
*[[Derived investigation level]]
*[[Derived limit]]
*[[Derived reference level]]
*[[Designated area]]
*Detector dose indicator (see [[Exposure index]])
*[[Detector quantum efficiency]]
*[[Deterministic effect]]
*[[Detriment-adjusted risk]]
*[[Diagnostic reference level]]
*[[Diastasis]]
*[[Differentiation]]
*[[Digital breast tomosynthesis]]
*[[Dignity]]
*[[Distribution coefficient]] (''K<sub>d</sub>'')
*DLP (see [[Dose-length product]])
*[[DNA damage signalling]]
*[[Dose criteria]]
*[[Dose of record (E)equivalent]]in an organ or tissue
*[[Dose of record Hp (10)limit]]
*[[Dose equivalent in an organ or tissuemodifying factor]]
*[[Dose limitof record (E)]]
*[[Dose modifying factorof record Hp (10)]]
*[[Dose per content function]]
*[[Dose rate effectiveness factor]]
*[[Dose-length product]]
*[[Dose-threshold hypothesis]]
*[[Doubling dose]]
*DQE (see [[Detector quantum efficiency]])
*DRL (see [[Diagnostic reference level]])
*[[DRL process]]
*[[DRL quantity]]
*[[DRL value]]
*[[DS02]]
*[[Effective half-life]]
*EI (see [[Exposure index]])
*[[Electron-capture decay]]
*[[Emergency procedures]]
*[[Employer]]
*[[Endogeneous excretion]]
*[[Ethics]]
*[[Evacuation]]
*[[Excess absolute risk]]
*[[Excretion rate (instantaneous)]]
*[[Exclusion]]
*[[Exempt waste]]
*[[Existing exposure situation]]
*[[Exogenous excretion]]
*[[Expanded and aligned radiation field]]
*[[Exponential survival curve]]
*[[Exposed individuals]]
*[[Exposure, external or internal]]
*[[Exposure (in the context of inhalation)]]
*[[Exposure index]]
*[[Exposure pathway]]
*[[Fluoroscopically guided interventions]]
*[[Fluoroscopically or computed tomography guided interventions]]
*[[Forbiddenness]]
*[[Fractionation]]
*[[Fractionation and dose delivery patterns]]
*[[Fractionation sensitivity]]
*[[Frequent flyer]]
*FSU (see [[Functional subunits]])
*[[Functional subunits]]
=== <big><span id="G">G</span></big> ===
*[[Gastrointestinal syndrome]]
*[[Gastrulation]]
*[[Gastroschisis]]
*[[GATA binding protein 2]]
*GATA-2 (see [[GATA binding protein 2]])
*[[Genomic integrity]]
*Geomagnetic cut-off rigidity (see [[Rigidity threshold]])
*[[Graded approach]]
*[[Graft vs host disease]]
*[[Granulocyte colony-stimulating factor]]
*[[Gray]] (Gy)
*[[Ground-level enhancement]]
*[[Growth factor]]
*[[Growth fraction]]
*[[Half-life, physical]]
*HATM (see [[Human Alimentary Tract Model]]])
*[[Hazard]]
*[[Hormones]]
*[[Hounsfield unit]]
*HRTM (see [[Human Respiratory Tract Model]])
*[[Human Alimentary Tract Model]]
*[[Human respiratory tract modelRespiratory Tract Model]]
*[[Hyperbaric oxygen]]
*[[Hyperfractionation]]
*[[Hypertrophic cardiomyopathy]]
=== <big><span id="I">I</span></big> ===
*[[ICRU 4-element tissue]]
*[[ICRU sphere]]
*[[Immune system]]
*IMRT (see [[Intensity-modulated radiotherapy]])
*[[In vivo radiobioassay]]
*[[Institutional control]]
*[[Intervention]]
*[[Intensity-modulated radiotherapy]]
*[[Intake]]
=== <big><span id="L">L</span></big> ===
*[[Lag]]
*[[Late normal tissue responses]]
*[[LD 50/30|LD<sub>50/30</sub>]]
*LET (see *[[Linear energy transfer]]) *[[Licensee]]
*[[Life Span Study]]
*LLE (see [[Lifetime risk estimates]])
*[[Local DRL]]
*Loss of Life Expectancy (see [[Lifetime risk estimates]])
*[[Mass median diameter]]
*MDCT (see [[Multi-detector computed tomography]])
*[[Mean glandular dose]]
*[[Measured quantity]]
*[[Mitigation]]
*MMD (see *[[Mass median diameter]]) *[[Molecular imaging]] *[[Multifactorial diseases]]
*[[Multiplicative risk projection model]]
*[[Multistage tumorigenesis]]
*[[Multitarget equation]]
*[[Multi-detector computed tomography]]
*[[Mutation component]]
=== <big><span id="N">N</span></big> ===
*[[National radon survey]]
*[[National DRL]]
*[[Naturally occurring radioactive material]]
*NHEJ (see [[Non-homologous end joining]])
*[[Noise]] (in imaging)
*[[Nominal value]]
*[[Nominal risk coefficient]]
*[[Normal tissue complication probability]]
*[[Notification value]] (in CT)
*[[Nuclear medicine]]
*[[Nuclear track detectors]]
=== <big><span id="O">O</span></big> ===
*OAR (see [[Organ at risk]])
*[[Occupancy factor]]
*[[Occupational exposure]]
*OEA (see [[Oxygen enhancement ratio]])
*[[OLINDA/EXM]]
*[[Oncogene]]
*[[Operating management]]
*[[Operational quantity]]
*[[Optimisation]]
*[[Optimisation of protection]] *Organ absorbed dose (see [[Organ/tissue absorbed dose]])
*[[Organ absorbed doseat risk]] (see [[Organ/tissue absorbed dose]])
*[[Organ dose equivalent]]
*[[Organ/tissue absorbed dose]]
*[[Other (systemic) tissues]]
*[[Oversight]]
*[[Oxygen enhancement ratio]]
=== <big><span id="P">P</span></big> ===
*Particle fluence (see [[Fluence]])
*[[Particle transport]](in biokinetics)
*[[Particle radiance]]
*[[Pelagic]]
*[[Pencil beam]]
*[[Percutaneous coronary intervention]]
*[[Pharynx]]
*[[Pilomatricoma]]
*[[Planned exposure situation]]
*[[Potential exposure]]
*[[Potential recoverability correction factor]]
*[[Potentially lethal damage repair]]
*[[Practical radiological protection culture]]
*[[Practice]]
*PRCF (see [[Potential recoverability correction factor]])
*[[Prevailing circumstances]]
*[[Principle of optimisation]]
*[[Principles of protection]]
*[[Procedural values]]
*[[Projected dose]]
*[[Protection quantities]]
*[[Protection strategy]]
*[[Qualified expert]]
*[[Quality control testing]] (x-ray equipment)
*[[Quality factor]], Q(L)
*[[Radiation weighting factor]], w<sub>R</sub>
*[[Radiation-induced second cancer]]
*[[Radiation-induced secondary malignancy]]
*[[Radiation worker]]
*[[Radioactive substance]]
*[[Radioactive waste]]
*[[Radioactivity]]
*[[Radiographer]]
*[[Radiological attack]]
*[[Radiological controlled area]]
*[[Radiosensitivity, cellular]]
*[[Radon progeny]]
*[[Radon-prone area]]
*RAP (see [[Reference Animal and Plant]])
*[[Ras]]
*[[Rb]]
*RBE (see [[Relative biological effectiveness]])
*[[Recovery (cellular or tissue)]]
*[[Redox]]
*[[Reference air kerma]]
*[[Reference Animal and Plant]]
*[[Reference biokinetic model]]
*[[Referrer]] *Reference female (see [[Reference IndividualPerson]])
*[[Reference individual]]
*[[Reference level]]
*Reference male (see [[Reference IndividualPerson]])
*[[Reference parameter value]]
*[[Reference phantom]]
*[[Reference value]]
*[[Reference worker]]
*[[Region]]
*[[Regional diagnostic reference levels]]
*[[Registry]]
*REID (see [[Lifetime risk estimates]])
*[[Rigidity threshold]]
*[[Rehabilitation of living conditions]]
*[[Relative risk]]
*[[Relative survival]]
*[[Relocation]]
*[[Risk model]]
*RISM (see [[Radiation-induced secondary malignancy]])
*Risk of exposure-induced death (see (see [[Lifetime risk estimates]])
=== <big><span id="S">S</span></big> ===
*[[S coefficient (radiation weighted)]] S<sub>W</sub>[(r<sub>T</sub>←r<sub>s</sub>)]
* SAF (see [[Specific absorbed fraction]])
*[[Safety case]]
*[[Safety]]
*[[Safety culture]]
*[[Scintigraphy]]
*[[Sealed source]]
*[[Secondary radiation]]
*[[Secretory cells]]
*[[Security]]
*[[Security screening]]
*SEE (see [[Specific effective energy]]]
*[[Severe deterministic injury]]
*[[Sheltering]]
*[[Shielding]]
*[[Sievert]] (Sv)
*[[Size-specific dose estimate]]
*SLDR (see [[Sublethal damage repair]])
*[[Slice]] (in CT & CBCT)
*[[Slow repair]]
*SOBP (see [[Spread-out Bragg peak]])
*[[Solar cosmic radiation]]
*[[Solar cycle]]
*[[Solar flare]]
*[[Solar particle event]]
*[[Source-related]]
*[[Source-related assessment]]
*[[South Atlantic anomaly]]
*[[Spontaneous fission]]
*[[Spread-out Bragg peak]]
*[[Stakeholder]]
*[[Standard-size adult]]
*[[Stem cell]]
*[[Stenosis]]
*[[Substantial radiation dose level]]
*[[Superposition principle]] (in dosimetry)
*[[Supervised area]]
*[[Surface contamination]]
*[[Systemic model]]
=== <big><span id="T">T</span></big> ===
*[[Tachycardia]]
*[[Telangiectasia]]
*[[Teratocarcinoma]]
*[[Thermodynamic diameter]]
*[[Threshold dose for tissue reactions]]
*[[Threshold levelslevel]] *Tissue absorbed dose (see [[Organ/tissue absorbed dose]])
*[[Tissue absorbed doseThoron progeny]] (see [[Organ/tissue absorbed dose]])
*[[Thyroid blocking]]
*[[Time factor]]
*[[Time-resolved computed tomography]]
*[[Tissue equivalent material]]
*[[Tolerability]]
*[[Tolerance dose]] (in Radiotherapy)
*[[Track structure]]
*[[Translocation]]
*[[Transmission detection system]]
*[[Transparency]]
*[[Trapped particles]]
*[[Treatment preparation in radiotherapy]]
*[[Trophic level]]
*[[Types of materials]]
*[[Typical value]] (for DRL)
=== <big><span id="U">U</span></big> ===
*[[Unsealed source]]
*[[Upper reference levels]]
*[[Uptake]]
*[[Waste disposal]]
*[[Waste management]]
*[[Wisdom]]
*WL (see [[Working level]])
*WLM (see [[Working level month]])
*[[Worker]]
*[[Working level]]
*[[Working level month]]
*w<sub>T</sub> (see [[Tissue weighting factor]])
